Minerva Neurosciences (NERV) Short-Term Debt issuances (2014 - 2015)
Minerva Neurosciences posted quarterly Short-Term Debt issuances of $10.0 million for Q1 2015, up 1900.0% year-on-year from $500000.0 in Q1 2014, and up 623.16% on a QoQ basis from $1.4 million in Q2 2014.
Minerva Neurosciences (NERV) has 2 years of Short-Term Debt issuances data on file, last reported at $10.0 million in Q1 2015.
- For the quarter ending Q1 2015, Short-Term Debt issuances rose 1900.0% year-over-year to $10.0 million; the trailing twelve-month figure through Sep 2015 stood at $10.0 million (changed N/A YoY), and the FY2014 full-year result was $1.9 million, changed N/A from the prior year.
- Short-Term Debt issuances for Q1 2015 stood at $10.0 million, up from $1.4 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $10.0 million in Q1 2015 and bottomed at $500000.0 in Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -33,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 10.00 Mn |
| Mar 31, 2015 | 10.00 Mn |
| Jun 30, 2014 | 1.38 Mn |
| Jun 30, 2014 | 1.38 Mn |
| Mar 31, 2014 | 500,000.00 |
| Mar 31, 2014 | 500,000.00 |